Latest Biotech News

Avidity Biosciences reported positive early to mid-stage clinical data for del-zota in Duchenne muscular dystrophy, showing reversal of disease progression and functional improvements. The company...

Eppendorf launched the VisioNize box 2, a next-generation hardware solution to enhance laboratory device connectivity, monitoring, and management. Complementing its cloud-based VisioNize Lab...

The FDA’s top drug regulator denied reports suggesting a move to abandon certain advisory committee meetings that review contentious drug applications. Concurrently, FDA officials plan to present...

Avidity Biosciences released promising early and midstage Phase I/II data for del-zota, an antibody-oligonucleotide conjugate targeting Duchenne muscular dystrophy. Treated patients showed...

Remynd NV reported positive results from its Phase IIa trial of REM-127, a novel Alzheimer’s candidate that targets calcium homeostasis disruption caused by pathological tau. The...

Following recent industry shifts, a former senior cell and gene therapy regulator from the FDA has joined Eli Lilly in a strategic policy role focused on the same therapeutic area. Simultaneously,...

MGI has introduced the T7+ high-throughput sequencer building on its successful DNBSEQ-T7 platform. The new instrument can generate over 14TB of data in 24 hours, doubling throughput and reducing...

VedaBio has secured CRISPR diagnostic intellectual property rights from Mammoth Biosciences to advance its amplification-free syndromic point-of-care molecular diagnostic platform. Leveraging a...

Researchers at Rockefeller University harnessed terabase-scale long-read sequencing of soil metagenomes to recover hundreds of previously unknown bacterial genomes and discover new antibiotic...

A recent report reveals FDA-approved biosimilars have generated $56.2 billion in savings since 2015 but face adoption challenges due to payer practices and pipeline gaps. Biosimilars hold dominant...

Belite Bio announced completion of the final subject visit in its two-year, Phase 3 DRAGON clinical trial evaluating Tinlarebant for Stargardt disease type 1, a degenerative retinal disorder with...

The field of nanomedicine is providing new drug delivery approaches to address metastatic cancer, a leading cause of mortality. By utilizing nanoscale formulations, researchers aim to improve...

Researchers report that AI-designed peptides are revolutionizing drug discovery by rapidly generating candidates that were previously unimagined. These advances, highlighted by experts including...

Lila Sciences is nearing a massive Series A funding round exceeding $300 million, as reported exclusively by Endpoints News. The company aims to back its vision of building "scientific...

The biopharma sector continues to attract substantial investment, with year-to-date financing data showing robust public and private capital influx. Notably, companies like Goodpath secured $18...

Cutting-edge studies unveil new mechanisms pertinent to Alzheimer’s disease and related neurodegenerative conditions. Aarhus University researchers identified defects in exosome production linked...

Rockefeller University researchers have pioneered terabase-scale long-read sequencing of soil metagenomes to unveil novel bioactive molecules, including two new antibiotic leads. This...

Recent developments include promising clinical and preclinical data shaping oncology treatments. Avidity Biosciences disclosed early and midstage trial results for del-zota, showing reversal of...

Further advances have emerged in bioprocessing and laboratory digitalization. Eppendorf launched the VisioNize box 2, enhancing lab device connectivity and cloud-based monitoring for improved...

Pharmaceutical giants continue to reconsider investments in the UK amid evolving market conditions. AstraZeneca paused a $271 million expansion at its Cambridge research site, following similar...